07Jan
DEAL WATCH: End-of-Year Biosimilar Agreements
Following the string of biosimilar agreements announced in early November, a number of additional transactions were announced in early December, bringing 2019 to a roaring close with global biosimilars deals. On December 1, 2019, Luye Pharma Group...
By:
Goodwin
Related
AB 51 is the California Bill which attempts to ban certain mandatory employment arbitration agreemen...
Read More >
We have previously written about how public-private partnerships ("P3s") are on the rise in the Unit...
Read More >
Salesforce recently announced the acquisition of Slack, which is certain to drive new and exciting c...
Read More >
Where does creativity fit into compliance? In more places than you think. Problem-solving, accountab...
Read More >
Dans un arrêt du 25 novembre 2020, la chambre criminelle de la Cour de cassation a annoncé un revire...
Read More >
The U.S. Department of Homeland Security (DHS) has proposed a rule that would make drastic changes t...
Read More >